
WuXi Biologics
Offering End-to-End Solutions
by gavin guo | Dec 12, 2024 | News & Resources - Webinars & Podcasts
Antibody-drug conjugate (ADC), is one of the fastest growing fields in therapy for life-threatening diseases. Its novel mechanism of action, target for unmet serious diseases and significant therapeutic effect has led the expedited development and approval of several...by gavin guo | Aug 1, 2024 | News & Resources - Press Releases, press-releases
Leon: Fantastic! Now I think everyone in the audience and around the world understands why we’ve invited three experts who definitely have many decades of experience in their respective fields, so let’s dive into it today. First, we will talk about how CMC...by gavin guo | Aug 11, 2023 | News & Resources - Press Releases, press-releases
SHANGHAI, Aug 11, 2023—WuXi XDC, a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on the ADC and broader bioconjugate market, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies...by gavin guo | Aug 8, 2023 | News & Resources - Publications
by gavin guo | Aug 8, 2023 | News & Resources - Publications
You are leaving WuXi Biologics Website, after which our Privacy Notice will not apply. Please keep it in mind the protection of your privacy. Are you willing to proceed?